ANEUROTECH
ActiveThe annual accounts of ANEUROTECH for fiscal year 2025 show a net loss of 53% of the equity at the start of that year. The 2025 annual accounts show equity of €611k and a net result of €-702k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 31% of 213 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
42
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency46▼-18
Growth52=
Track record94
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity short (current ratio 0.33 against 0.46 in 2024; short-term debt: 17.1% and cash: 0.1% of total assets), and 79% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
22232425
2022 to 2025 · latest year €-702k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
31 d late
2024
30 d late
2023
30 d late
2022
92 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€611k▼ 53.5%
2024 · €1.31M
2022: €75k
2023: €1.97M
2024: €1.31M
2022 → 2025
Total assets
€2.91M▼ 14.5%
2024 · €3.41M
2022: €1.94M
2023: €4.00M
2024: €3.41M
2022 → 2025
Net result
€-702k▼ 7.1%
2024 · €-655k
2022: €-22k
2023: €-313k
2024: €-655k
2022 → 2025
Working capital
€-333k▼ 88.2%
2024 · €-177k
2022: €-474k
2023: €56k
2024: €-177k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€75k-€1.97M▲ 2,523%€1.31M▼ 33.3%€611k▼ 53.5%
Operating result€-18k-€-399k▼ 2,108%€-614k▼ 53.9%€-651k▼ 6.0%
Net result€-22k-€-313k▼ 1,334%€-655k▼ 109%€-702k▼ 7.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €651k in 2025 against €614k in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.91M
Fixed assets
€2.74M▼ 15.7%
Current assets
€167k▲ 11.0%
Equity and liabilities €2.91M
Equity
€611k▼ 53.5%
Debt
€2.30M▲ 9.9%
The debt ratio rises from 61.5% to 79.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€-32k▲
2024 · €-34k
Cash flow
€-83k▼
2024 · €-75k
Solvency
21.0%▼
2024 · 38.5%
Current ratio
0.33▼
2024 · 0.46
Quick ratio
0.33▼
2024 · 0.46
Debt / equity
3.77▲
2024 · 1.60
ROE
-114.8%▼
2024 · -49.9%
ROA
-24.1%▼
2024 · -19.2%
Interest coverage
-0.57▲
2024 · -0.69
Debt
€2.30M▲
2024 · €2.09M
Debt ≤ 1 year
€499k▲
2024 · €327k
Debt > 1 year
€1.80M▲
2024 · €1.77M
Income taxes
€-4k▲
2024 · €-7k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.41M€2.91M▼
Formation expenses20€3k€2k▼
Fixed assets21/28€3.25M€2.74M▼
Intangible fixed assets21€3.25M€2.74M▼
Current assets29/58€150k€167k▲
Amounts receivable within one year40/41€137k€165k▲
Other amounts receivable41€137k€165k▲
Cash at bank and in hand54/58€13k€2k▼
Equity and liabilities
Total equity and liabilities10/49€3.41M€2.91M▼
Equity10/15€1.31M€611k▼
Contributions10/11€2.09M€2.09M=
Reserves13€88k€88k=
Distributable reserves133€88k€88k=
Profit (loss) carried forward14€-861k€-1.56M▼
Amounts payable17/49€2.09M€2.30M▲
Amounts payable after more than one year17€1.77M€1.80M▲
Financial debts170/4€1.77M€1.80M▲
Amounts payable within one year42/48€327k€499k▲
Trade debts44€112k€151k▲
Suppliers440/4€112k€151k▲
Taxes, remuneration and social security45€55k€16k▼
Taxes450/3€55k€16k▼
Other amounts payable47/48€160k€332k▲
Accrued charges and deferred income492/3-€2k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€580k€619k▲
Other operating charges640/8€1k€1k▲
Gross operating margin9900€-33k€-31k▲
Operating profit (loss)9901€-614k€-651k▼
Financial income75/76B€907€2k▲
Recurring financial income75€907€2k▲
Financial charges65/66B€49k€56k▲
Recurring financial charges65€49k€56k▲
Profit (loss) for the period before taxes9903€-663k€-705k▼
Income taxes67/77€-7k€-4k▲
Profit (loss) for the period9904€-655k€-702k▼
Profit (loss) for the period to be appropriated9905€-655k€-702k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-861k€-1.56M▼
Profit (loss) brought forward from the previous period14P€-206k€-861k▼
Transfer from equity791/2€0-
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet €-702k
Net result drops to €-702k, the lowest in the series.
30-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 30 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
31-12
Financial
Liquidity triplescurrent ratio 1.19
Current ratio from 0.37 to 1.19; short-term debt falls from €750k to €299k.
31-12
Financial
Equity above €1MEq €1.97M ▲2523%
Equity rises from €75k to €1.97M.
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 92 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Alken · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Alkerstraat 30 A3570 AlkenGround area
892 m²
Building footprint
169 m²
Volume, LiDAR
949 m³
Parcel 73302E1060/00Y000, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ANEUROTECH
since 20222.330.918.017
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73302E1060/00Y000 | Flanders | 892 m² | 1 · 169 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CASC8
BE 0656.577.261
Keerbergen · Eq €612k
San'Up
BE 0693.818.729
Aywaille · Eq €609k
CellCarta Biosciences
BE 0661.567.021
Charleroi · Eq €607k
RHUMAT-OS
BE 0470.737.436
Waterloo · Eq €599k
PERJUSTINAGE
BE 0466.819.527
Péruwelz · Eq €599k
Of 761 companies in sector 72101 we hold annual accounts for 481. 314 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-04-2022
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
71121Engineering and related technical consultancy, excluding land surveyors
71209Other technical testing and analysis
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.